Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shuji Nanjo is active.

Publication


Featured researches published by Shuji Nanjo.


European Journal of Heart Failure | 2011

Comparative analysis of the therapeutic effects of long-acting and short-acting loop diuretics in the treatment of chronic heart failure using 123I-metaiodobenzylguanidine scintigraphy

Shinji Hisatake; Shuji Nanjo; Shinichiro Fujimoto; Shohei Yamashina; Hitomi Yuzawa; Atsushi Namiki; Hajime Nakano; Junichi Yamazaki

Loop diuretics are essential for the treatment of chronic heart failure (CHF) but short‐acting diuretics are reported to induce sympathetic nervous system (SNS) activation. This study was performed to compare therapeutic effects of two loop diuretics, long‐acting azosemide and short‐acting furosemide, using 123I‐metaiodobenzylguanidine (123I‐MIBG) scintigraphy.


Journal of Cardiology | 2008

Scintigraphic studies on the etiology of Ampulla Cardiomyopathy

Yasuto Uchida; Shuji Nanjo; Shinichiro Fujimoto; Shohei Yamashina; Kenji Wagatsma; Hajime Nakano; Junichi Yamazaki

BACKGROUND Although there are many reports on Ampulla Cardiomyopathy, its etiologic mechanisms are not well known. AIM Etiology of Ampulla Cardiomyopathy was investigated by myocardial scintigraphy with various nuclear tracers. SUBJECTS AND METHODS In nine patients with Ampulla Cardiomyopathy, myocardial scintigraphy was performed at acute, subacute and chronic phases. Total defect score (TDS) of tallium-201 (Tl) or technetrium-99m sestamibi (MIBI) myocardial perfusion and iodine-123-beta-methyl-p-iodophenyl penta-decanoic acid (BMIPP) scintigraphies was calculated. Cardio-mediastinal ratio (H/M) and washout rate (WR) of early and delayed images of iodine-123-meta-iodobenzylguanidine (MIBG) scintigraphy were also calculated. The patients in whom TDS of myocardial perfusion scintigraphy at acute phase was 0, were classified into group N (n = 5) and those with TDS > or = 1 into group D (n = 4). RESULTS TDS of BMIPP at acute, subacute and chronic phases was higher in D than in N; 28.8 +/- 10.3 vs. 7.2 4.7 (p = 0.0039), 15.5 +/- 2.1 vs. 1.0 +/- 0.8 (p < 0.0001) and 2.7 +/- 1.2 vs. 0 (p = 0.05), respectively. WR of MIBG at acute phase was also higher in D (50.3 +/- 5.7% vs. 36.6 +/- 10.5%, p = 0.05). H/M (dH/M) on the delayed images and WR at chronic phase were not different between the two groups. H/M (eH/M) on the early images was lower in D. Blood noradrenaLine (ng/ml) at acute phase was higher in D than in N (1.21 +/- 0.55 vs. 0.45 +/- 0.33, p < 0.05). Left ventricular ejection fraction (LVEF) was decreased in both at acute phase but it was lower in D than in N (48.1 +/- 3.7% vs. 69.9 +/- 9.7%, p < 0.05) at subacute phase. CONCLUSION These findings suggest that the etiology of Ampulla Cardiomyopathy is neurologically stunned myocardium induced by coronary microcirculatory disorder. Due to the significant amount of time that was necessary for normalization of wall motion in the D group, myocardial scintigraphy is believed to be also useful in assessment of severity.


Academic Radiology | 2002

Efficacy of contrast-enhanced MR imaging in cardiomyopathy: an experimental study using Bio14.6 hamsters.

Shuji Nanjo; Junichi Yamazaki; Kohki Yoshikawa; Myouta Miura; Atsushi Seno

RATIONALE AND OBJECTIVES Myocardial fibrosis was evaluated with magnetic resonance (MR) imaging in Bio14.6 hamsters. MATERIALS AND METHODS Gated gradient-echo T1-weighted images and spin-echo images with gadopentetate dimeglumine enhancement (0.2 mmol/kg) were obtained. RESULTS Myocardial enhancement persisted for 13 minutes after administration of gadopentetate dimeglumine, and myocardial signal intensity peaked at 13 minutes on gradient-echo T1-weighted images. The enhanced areas were greater in Bio14.6 hamsters at 25-42 weeks than at 10 weeks. Pathologic data revealed enhancement with inflammation at 10 weeks and fibrosis with vessel proliferation at 25-42 weeks. Pathologic fibrotic change was greater at 32-42 weeks than at 10 weeks. The myocardium of 42-week-old Bio14.6 hamsters showed remarkable contrast enhancement, which continued for 13 minutes. There was no correlation between gadolinium enhancement and pathologic findings in the evaluation of myocardial degeneration and fibrosis. CONCLUSION Gadolinium-enhanced MR imaging was useful for estimating myocardial fibrotic changes with vessel proliferation and myocardial damage.


Annals of Nuclear Medicine | 2004

Primary idiopathic chylopericardium: Report of two cases

Shuji Nanjo; Junichi Yamazaki; Masahiko Tsubuku; Takeshi Ohyama; Takayuki Ohtsuka; Hajime Nakano

Primary chylopericardium is an extremely rare disease. This report presents two cases of this disease, in a 47-year-old man and 21-year-old woman. Both cases were given diagnosis of primary chylopericardium by chylous pericardial fluid examination and lymphangio-scintigraphy which demonstrated abnormal communication between the left thoracic duct and the pericardial cavity.


American Heart Journal | 2001

Evaluation of β-blocker therapy in patients with dilated cardiomyopathy—Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography

Junichi Yamazaki; Hiroshi Muto; Toshio Kabano; Shohei Yamashina; Shuji Nanjo; Aritomo Inoue


Circulation | 2009

Correlation Between Left Ventricular Diastolic Function and Ejection Fraction in Dilated Cardiomyopathy Using Magnetic Resonance Imaging With Late Gadolinium Enhancement

Shuji Nanjo; Kohki Yoshikawa; Masahiko Harada; Yusuke Inoue; Atsushi Namiki; Hajime Nakano; Junichi Yamazaki


Circulation | 2011

Anatomical Characteristics of Myocardial Bridge in Patients With Myocardial Infarction by Multi-Detector Computed Tomography

Kazuhisa Takamura; Shinichiro Fujimoto; Shuji Nanjo; Rine Nakanishi; Shinji Hisatake; Atsushi Namiki; Yukio Ishikawa; Toshiharu Ishii; Junichi Yamazaki


International Heart Journal | 2006

Carvedilol Prevents Myocardial Fibrosis in Hamsters

Shuji Nanjo; Junichi Yamazaki; Kohki Yoshikawa; Toshiharu Ishii; Yuko Togane


Circulation | 2009

Evaluation of Sympathetic Activity by 123I-Metaiodobenzylguanidine Myocardial Scintigraphy in Dilated Cardiomyopathy Patients With Sleep Breathing Disorder

Shuji Nanjo; Yoshihiro Yamashiro; Shinichiro Fujimoto; Shohei Yamashina; Rine Nakanishi; Shunji Fukunaga; Aritomo Inoue; Atsushi Namiki; Hajime Nakano; Junichi Yamazaki


Academic Radiology | 1996

Contrast agent for magnetic resonance angiography: Experimental evaluation of superparamagnetic iron oxide composed of polysaccharide complex involving chondroitinsulfuric acid

Kohki Yoshikawa; Kazuo Yagi; Shuji Nanjo; Atsushi Seno; Takahiro Shiono; Kimiko Tobe; Shozo Suzuki

Collaboration


Dive into the Shuji Nanjo's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rine Nakanishi

Los Angeles Biomedical Research Institute

View shared research outputs
Top Co-Authors

Avatar

Kazuo Yagi

Tokyo Metropolitan University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge